All
| |
Merrion Pharmaceuticals Plc Announces Preliminary Results for the year ended 31 Dec 2009
Mar 8, 2010
|
543.7 KB |
| |
Merrion Pharmaceuticals plc announces issuance of key United States Patent, 2nd March 2010
Mar 2, 2010
|
56.0 KB |
| |
Merrion Pharmaceuticals Announces Participation at the 14th Annual Drug Delivery Partnerships, Orlando, Florida.
Jan 27, 2010
|
81.7 KB |
| |
Novo Nordisk starts phase 1 trial with oral insulin analogue - Merrion Pharmaceuticals earns USD 2 million milestone payment
Dec 7, 2009
|
52.6 KB |
| |
Merrion Pharmaceuticals Plc Announce the Official Opening of their New State of the Art Facility in Citywest 29th Oct 2009
Oct 29, 2009
|
62.4 KB |
| |
Merrion Pharmaceuticals Plc to Present at AACR-NCI-EORTC International Molecular Targets & Cancer Therapeutics Conference in Boston, MA
Oct 21, 2009
|
18.4 KB |
| |
Merrion Pharmaceuticals Plc Completion of Placing 15th Oct 2009.
Oct 15, 2009
|
139.8 KB |
| |
Merrion Pharmaceuticals Plc Announce Presentation at ASCO, 2009 Breast Cancer Symposium, San Francisco.
Oct 9, 2009
|
41.3 KB |
| |
Merrion Pharmaceuticals selected to present at prestigious UBS Global Life Sciences conference, Monday 21st Sept 2009
Sep 20, 2009
|
60.2 KB |
| |
Merrion Pharmaceuticals plc announces commencement of Second feasibility collaboration programme with the Swiss based Ferring Pharmaceuticals SA
Sep 14, 2009
|
41.9 KB |
| |
Merrion Pharmaceuticals plc Interim Results for the six months ended 30 June 2009
Sep 4, 2009
|
464.8 KB |
| |
Merrion Pharmaceuticals Plc Announces acquisition of new facility - 22th July 2009
Jul 22, 2009
|
27.8 KB |
| |
Merrion Pharmaceuticals Plc Announces positive Final results on key Phase II Orazol™ study
May 31, 2009
|
30.2 KB |
| |
Merrion Pharmaceuticals Plc Announces Preliminary results on Phase II Orazol™ study
May 15, 2009
|
44.3 KB |
| |
Merrion Pharmaceuticals 2008 Annual Report
Apr 23, 2009
|
337.3 KB |
| |
Merrion Pharmaceuticals Plc Announces Preliminary Results for the year ended 31 December 2008
Mar 16, 2009
|
140.5 KB |
| |
Merrion Pharmaceuticals Announces Commencement of Dosing of Orazol™ in US Clinical Study
Mar 10, 2009
|
27.1 KB |
| |
Merrion CEO, John Lynch, Addresses Biobusiness Conference, Geneva, Switzerland
Feb 18, 2009
|
26.2 KB |
| |
Merrion Pharmaceuticals Plc Announces Board Changes - 12th February 2009
Feb 12, 2009
|
29.5 KB |
| |
Merrion Completes Patient Enrolment in Phase IIb Study - February 10th 2009
Feb 10, 2009
|
25.9 KB |
|
|
